Medicare Enrolled
Dr. Matthew Harris, M.D.
Dermatology · Hinsdale, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Harris from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harris?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harris
Dr. Matthew Harris is a dermatology specialist in Hinsdale, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Harris performed 6,381 Medicare services across 2,512 unique beneficiaries.
Between the years covered by Open Payments, Dr. Harris received a total of $28,981 from 47 pharmaceutical and/or device companies across 1090 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harris is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 17% volume in IL
$28,981 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,381
Medicare services
Top 17% in IL for dermatology
2,512
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~319 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,706 | $5 | $13 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
917 | $66 | $162 |
| Ultrasound guidance for radiation therapy field placement Use of ultrasound imaging to help position radiation therapy fields accurately during treatment. |
665 | $148 | $280 |
| Radiation treatment planning, 1 area This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area. |
634 | $223 | $590 |
| Superficial or low voltage radiation treatment A radiation therapy procedure that delivers radiation to the surface of the body or uses low voltage energy. This treatment targets areas close to the skin. |
606 | $34 | $92 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
519 | $39 | $142 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
435 | $86 | $242 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
199 | $38 | $99 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
180 | $68 | $217 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
100 | $75 | $233 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
90 | $90 | $234 |
| Radiation treatment management, 5 sessions Oversight and management of a radiation therapy course consisting of five treatment sessions. |
86 | $158 | $417 |
| Calculation of radiation therapy dose | 41 | $54 | $142 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
38 | $1 | $3 |
| Design and construction of complex radiation treatment device This code covers the design and construction of a complex radiation treatment device. It does not specify the clinical purpose or conditions treated. |
34 | $101 | $272 |
| Simple radiation therapy planning This procedure involves the initial planning phase for radiation therapy treatment. It includes the setup and configuration required to prepare for delivering radiation to a specific area. |
29 | $56 | $156 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
25 | $36 | $119 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
24 | $138 | $341 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
21 | $47 | $165 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
18 | $53 | $214 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
14 | $42 | $116 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$28,981
Total received (2018-2024)
Avg $4,140/year across 7 years
Top 9% in IL for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
1,090
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,181 (73.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,801 (26.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,437
2023
$11,210
2022
$2,774
2021
$2,503
2020
$2,515
2019
$3,503
2018
$2,040
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$643
Dermavant Sciences, Inc.
$618
Arcutis Biotherapeutics, Inc.
$596
Janssen Biotech, Inc.
$543
Regeneron Healthcare Solutions, Inc.
$235
PFIZER INC.
$208
Novartis Pharmaceuticals Corporation
$191
GENZYME CORPORATION
$187
Galderma Laboratories, L.P.
$178
UCB, Inc.
$176
Verrica Pharmaceuticals Inc.
$155
LEO Pharma Inc.
$113
SUN PHARMACEUTICAL INDUSTRIES INC.
$108
Lilly USA, LLC
$103
Amgen Inc.
$90
Biofrontera Inc.
$63
E.R. Squibb & Sons, L.L.C.
$59
Ortho Dermatologics, a division of Bausch Health US, LLC
$58
Organon Llc
$45
Incyte Corporation
$35
STRATA Skin Sciences, Inc.
$33
Top 3 companies account for 41.9% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$8,241
Galderma Laboratories, L.P.
$3,805
ABBVIE INC.
$1,960
Janssen Biotech, Inc.
$1,768
Dermavant Sciences, Inc.
$1,145
Novartis Pharmaceuticals Corporation
$1,064
Regeneron Healthcare Solutions, Inc.
$1,005
Sun Pharmaceutical Industries Inc.
$837
AbbVie Inc.
$834
GENZYME CORPORATION
$792
PFIZER INC.
$749
Amgen Inc.
$689
Arcutis Biotherapeutics, Inc.
$634
Lilly USA, LLC
$556
Ortho Dermatologics, a division of Bausch Health US, LLC
$480
LEO Pharma Inc.
$476
AbbVie, Inc.
$460
Janssen Scientific Affairs, LLC
$451
Merz North America, Inc.
$419
Biofrontera Inc.
$250
Celgene Corporation
$240
Incyte Corporation
$214
STRATA Skin Sciences, Inc.
$202
E.R. Squibb & Sons, L.L.C.
$190
SUN PHARMACEUTICAL INDUSTRIES INC.
$188
Verrica Pharmaceuticals Inc.
$178
VYNE Pharmaceuticals Inc.
$170
DERMIRA, INC.
$133
MAYNE PHARMA INC.
$116
EPI Health, LLC
$92
Mayne Pharma Inc.
$87
MAYNE PHARMA COMMERCIAL LLC
$60
Almirall LLC
$59
Encore Dermatology Inc.
$50
Organon Llc
$45
Mission Pharmacal Company
$43
Allergan Inc.
$42
Allergan, Inc.
$42
Bayer HealthCare Pharmaceuticals Inc.
$38
Journey Medical Corporation
$38
Taro Pharmaceuticals USA, Inc.
$26
SANOFI-AVENTIS U.S. LLC
$26
DUSA Pharmaceuticals, Inc.
$21
Aclaris Therapeutics, Inc.
$19
Kyowa Kirin, Inc.
$18
Sebela Pharmaceuticals Inc.
$16
Helsinn Therapeutics (U.S.), Inc.
$12
Top 3 companies account for 48.3% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Ameluz · Avar · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dermatological Psoriasis and Vitiligo Treatment · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · FINACEA · Finacea · HADLIMA · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · LIBTAYO · ODOMZO · OPZELURA · ORACEA · Otezla · Ovace · PICATO · POTELIGEO · PRAMOSONE · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRI-LUMA · TRILUMA · Tremfya · USP) 0.1% · VALCHLOR · VTAMA · Veltin · Verdeso · Winlevi · XEOMIN · XTRAC · Xeomin · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for dermatology in IL.
Geographic Context
Dermatologists within 10 mi
401
Per 100K population
43.2
County median income
$110,502
Nearest hospital
UCHICAGO MEDICINE ADVENTHEALTH HINSDALE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Harris is a clinical cardiology specialist, with above-average Medicare volume (top 17% in IL), with low-engagement industry engagement in the top 9% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Harris experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Harris performed 1,706 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harris receive payments from pharmaceutical companies?
Yes. Dr. Harris received a total of $28,981 from 47 companies across 1,090 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harris's costs compare to other dermatologists in Hinsdale?
Dr. Harris's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harris) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Hinsdale
Browse dermatologists in Hinsdale ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in IL
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in IL
Which IL dermatologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology